Anticancer and Anti-Inflammatory Activity of Probiotic Lactococcus lactis NK34 |
Han, Kyoung Jun
(Department of Food Science and Biotechnology of Animal Resources, Konkuk University)
Lee, Na-Kyoung (Department of Food Science and Biotechnology of Animal Resources, Konkuk University) Park, Hoon (Department of Food Science, Sun Moon University) Paik, Hyun-Dong (Department of Food Science and Biotechnology of Animal Resources, Konkuk University) |
1 | Chang JH, Shin YY, Chae SK, Chee KM. 2010. Probiotic characteristics of lactic acid isolated from kimchi. J. Appl. Microbiol. 109: 220-230. DOI |
2 | Lee NK, Noh JE, Choi GH, Park E, Chang HI, Yun CW, et al. 2007. Potential probiotic properties of Lactococcus lactis NK34 isolated from jeotgal. Food Sci. Biotechnol. 16: 843-847. |
3 | Lee NK, Kim SY, Han KJ, Eom SJ, Paik HD. 2014. Probiotic potential of Lactobacillus strains with anti-allergic effects from kimchi for yogurt starters. LWT Food Sci. Technol. 58: 130-134. DOI |
4 | Zhou X, Wang Y, Li W. 2010. Inhibition ability of probiotic, Lactococcus lactis, against A. hydrophila and study of its immunostimulatory effect in tilapia (Oreochromis niloticus). Int. J. Eng. Sci. Technol. 2: 73-80. |
5 | Baumgart DC, Thomas S, Przesdzing I, Metzke D, Bielecki C, Lehmann SM, et al. 2009. Exaggerated inflammatory response of primary human myeloid dendritic cells to lipopolysaccharide in patients with inflammatory bowel disease. Clin. Exp. Immunol. 157: 423-436. DOI |
6 | Commane D, Hughes R, Shortt C, Rowland I. 2005. The potential mechanisms involved in the anti-carcinogenic action of probiotics. Mut. Res. 591: 276-289. DOI |
7 | Festen EAM, Szperl AM, Weersma RK, Wikmenga C, Wapenaar MC. 2009. Inflammatory bowel disease and celiac disease: overlaps in the pathology and genetics, and their potential drug targets. Curr. Drug Targets Immune Endocr. Metab. Disord. 9: 199-218. DOI |
8 | Heo WS, Kim YR, Kim EY, Bai S, Kong IS. 2013. Effects of dietary probiotic, Lactococcus lactis subsp. lactis I2, supplementation on the growth and immune response of olive flounder (Paralichthys olivaceus). Aquaculture 376-379: 20-24. DOI |
9 | Lakatos L, Lakatos PL. 2006. Is the incidence and prevalence of inflammatory bowel diseases increasing in Eastern Europe? Postgrad. Med. J. 82: 332-337. DOI |
10 | Otte JM, Mahjurian-Namari R, Brand S, Werner I, Schmidt WE, Schmitz F. 2009. Probiotics regulate the expression of COX-2 in intestinal epithelial cells. Nutr. Cancer 61: 103-113. DOI |
11 | Ouwehand AC. 2011. Allergenic effects of probiotics. J. Nutr. 137: 794S-797S. |
12 | Lee NK, Son SH, Jeon EB, Kim GH, Lee JY, Paik HD. 2015. The prophylactic effect of probiotic Bacillus polyfermenticus KU3 against cancer cells. J. Funct. Foods 14: 513-518. DOI |
13 | Marcinkiewicz J, Ciszek M, Bobek M, Strus M, Heczko PB, Kurnyta M, et al. 2007. Differential inflammatory mediator response in vitro from murine macrophages to lactobacilli and pathogenic intestinal bacteria. Int. J. Exp. Pathol. 88: 155-164. DOI |
14 | O’Sullivan GC, Kelly P, O’Halloran S, Collins C, Collins JK, Dunne C, Shanahan F. 2005. Probiotics: an emerging therapy. Curr. Pharm. Des. 11: 3-10. DOI |
15 | Shukla R, Iliev I, Goyal A. 2014. Leuconostoc mesenteroides NRRL B-1149 as probiotic and its dextran with anticancer properties. J. Biosci. Biotechnol. 3: 79-87. |
16 | Westbrook AM, Szakmary A, Schiestl RH. 2010. Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models. Mutat. Res. 705: 40-59. DOI |